Endexx (EDXC) Stock Price

Endexx Price

OTC·CLOSED
0.00
​
Market closed

Revenue has compounded at 30.2% per year over the past 4 years to 2.14 M USD. Endexx's net margin stands at -228.5%, up from -335.9% several years earlier.

Endexx stock price

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Endexx business model & stock analysis

Endexx Corp. develops hemp-derived cannabidiol-based products through its subsidiaries, selling oils, extracts, topicals, and pet products via its e-commerce site cbdunlimited.com and other online and in-store retailers. The Gorilla-Tek division provides an automated dispensing system for secure distribution of hemp-based products. Seed-to-Shelf offers compliance and inventory tracking technology for regulated hemp product management. The company targets consumers seeking therapeutic relief for pain and inflammation, as well as retailers and pharmacies needing regulatory support systems. Endexx Corp. generates revenue from direct sales of CBD products through its website and retail partners, automated dispensing systems sold to businesses, and technology solutions like Seed-to-Shelf for industry compliance. Its consumer products are marketed to individuals and pet owners, while its technology services are sold to hemp industry businesses requiring regulatory and operational support. The company's subsidiaries handle product development, retail distribution, and technology services for the hemp sector. The firm's primary revenue streams include e-commerce sales of CBD oils, extracts, topicals, and pet products, automated dispensing systems for secure product distribution, and technology platforms such as Seed-to-Shelf for compliance and inventory management. These offerings cater to both end consumers and business clients in the hemp industry, with the Gorilla-Tek division focusing on dispensing solutions and Seed-to-Shelf supporting pharmacy and retail operations through process management systems.

Frequently asked questions about Endexx

6 analysts currently rate the Endexx stock: 0 recommend buying, 3 holding and 3 selling.

Converted at the current exchange rate, the Endexx share trades at 0.00 EUR (0.00 USD).

The revenue cannot currently be calculated for Endexx.

The profit cannot currently be calculated for Endexx.

The P/E ratio cannot be calculated for Endexx at the moment.

The P/S cannot be calculated for Endexx currently.

The Eulerpool Quality Score for Endexx is 5/10.

The ISIN of Endexx is US29259K1025. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The ticker of Endexx is EDXC. The ticker symbol is used to trade Endexx shares on the stock exchange.

Fair ValueTerminal
0.00 USD
Over-/UndervaluationTerminal
Fairly valued
Sector
Industry
Pharmaceuticals
Number of shares
Employees
Revenue growth Ø5 years
EBIT growth Ø5 years
Net Income growth Ø5 years
Website endexx.com
Currency
USD
Initial public offering
Aug 3, 2001
ISIN
US29259K1025
Cusip
29259K102
Market capitalization
57,185.00 USDMicro Cap
52-Week Range
PEG
—
P/E ratio
P/Ee 2023
-0.01
P/S
P/Se
0.02
EV/EBIT
—
P/B Ratio
—
ROE (Return on Equity)
ROA (Return on Assets)
ROCE (Return on Capital Employed)
ROIC (Return on Invested Capital)
-845.65 %
Last updated Nov 11, 2026, 5:01 AM

Endexx Peer Group

Endexx Ticker

OTC · EDXC

Endexx FIGI

EDXC:US · BBG000BFD4L7EDXC:PQ · BBG000BFDD19EDXC:UV · BBG000BFDDZ2

All fundamentals and in-depth analysis of Endexx

Our stock analysis for Endexx stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Endexx. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.